Using AtorVASTatin to Prevent VAscular Inflammatory OccLUSion in the Critically Ill "VASTVALUS"


Phase 2/3 Results N/A

Summary of Purpose

Patients are admitted to the critical care unit of the hospital because of medical conditions that have a high likelihood of causing severe problems with blood flow, breathing, or brain function. These conditions also have a high likelihood of causing death. Approximately 10 to 15% of all critically ill patients die in hospital. A large amount of scientific evidence suggests that a substantial proportion of...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 15 December 2011.

1 Apr 2009 20 Jul 2009 1 Aug 2009 1 Sep 2011 1 Dec 2011 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Prevention
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment


  • Michael j Jacka, MD

  • Michelle Graham, MD